New Studies Demonstrate Reliable Efficacy Using LevitraT (vardenafil HCl)

Start

New findings on the long-term benefits of LevitraT showed that men with erectile dysfunction (ED) taking LevitraT reported clinically significant, sustained improvement in erectile function (EF) over a two-year period. LevitraT was also shown to be a reliable and fast-acting agent for the treatment of ED in patients participating in clinical trials. Results from the new studies were presented earlier at the Second International Consultation on Erectile and Sexual Dysfunctions, Paris, France, a meeting supported by the World Health Organisation.

“It is impressive to find that LevitraT’s excellent efficacy is sustained for an extended period of time. If an ED drug loses its effect over time, the full benefits of treatment are lost and, as a result, men may lose confidence in their therapy and their sexual function,” said Dr Christopher Stief, a professor in the department of urology at Medizinische Hochschule in Hannover , Germany .

Study participants reported improved erectile function throughout two years

A total of 755 men with ED completed a one-year treatment period with LevitraT. Of those, 566 men agreed to continue to receive Levitra 10 mg or 20 mg in a double-blind study for an additional year. Of the 479 men who completed the study, two-year results showed:1

  • 9 in 10 men taking LevitraT reported improved erections throughout the study period (92% of men taking LevitraT 20 mg and 90% of men taking LevitraT 10 mg).
  • Not only did LevitraT significantly improve men’s erectile function, but study participants were reportedly five times more likely, on average, to maintain their erections through completion of sexual intercourse (89% vs. 17% at baseline for men taking LevitraT 20 mg and 87% vs. 16% at baseline for men taking LevitraT 10 mg).

End

Leave a Reply

You must be logged in to post a comment.